PL3630806T3 - Analogi peptydów gip o długotrwałym działaniu - Google Patents

Analogi peptydów gip o długotrwałym działaniu

Info

Publication number
PL3630806T3
PL3630806T3 PL18728872.5T PL18728872T PL3630806T3 PL 3630806 T3 PL3630806 T3 PL 3630806T3 PL 18728872 T PL18728872 T PL 18728872T PL 3630806 T3 PL3630806 T3 PL 3630806T3
Authority
PL
Poland
Prior art keywords
long
peptide analogues
gip peptide
acting
acting gip
Prior art date
Application number
PL18728872.5T
Other languages
English (en)
Polish (pl)
Inventor
Mette Marie Rosenkilde
Jens Juul Holst
Lærke Smidt GASBJERG
Alexander Hovard SPARRE-ULRICH
Maria Buur Nordskov Gabe
Original Assignee
The University Of Copenhagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Copenhagen filed Critical The University Of Copenhagen
Publication of PL3630806T3 publication Critical patent/PL3630806T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
PL18728872.5T 2017-05-31 2018-05-31 Analogi peptydów gip o długotrwałym działaniu PL3630806T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17173628 2017-05-31
PCT/EP2018/064355 WO2018220123A1 (en) 2017-05-31 2018-05-31 Long-acting gip peptide analogues

Publications (1)

Publication Number Publication Date
PL3630806T3 true PL3630806T3 (pl) 2024-05-13

Family

ID=59021262

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18728872.5T PL3630806T3 (pl) 2017-05-31 2018-05-31 Analogi peptydów gip o długotrwałym działaniu

Country Status (10)

Country Link
US (1) US11572399B2 (cg-RX-API-DMAC7.html)
EP (2) EP3630806B1 (cg-RX-API-DMAC7.html)
JP (1) JP2020521784A (cg-RX-API-DMAC7.html)
KR (1) KR102743887B1 (cg-RX-API-DMAC7.html)
CN (1) CN110691788B (cg-RX-API-DMAC7.html)
AU (1) AU2018276434B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019025195A8 (cg-RX-API-DMAC7.html)
ES (1) ES2972848T3 (cg-RX-API-DMAC7.html)
PL (1) PL3630806T3 (cg-RX-API-DMAC7.html)
WO (1) WO2018220123A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2685987T3 (es) 2014-09-05 2018-10-15 University Of Copenhagen Análogos de péptidos gip
BR112019025195A8 (pt) 2017-05-31 2020-07-07 Univ Copenhagen análogos do peptídeo gip de ação prolongada
CA3097939A1 (en) 2018-05-04 2019-11-07 Novo Nordisk A/S Gip derivatives and uses thereof
US12187773B2 (en) * 2018-12-03 2025-01-07 Antag Therapeutics Aps Modified GIP peptide analogues
WO2023139106A2 (en) 2022-01-18 2023-07-27 Novo Nordisk A/S Long-acting gipr antagonists

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869602A (en) 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
US6268343B1 (en) 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
WO1998024464A1 (en) 1996-12-03 1998-06-11 Trustees Of Boston University Specific antagonists for glucose-dependent insulinotropic polypeptide (gip)
BR9906857A (pt) 1998-01-30 2000-11-14 Novo Nordisk As Seringas de injeção
WO1999043708A1 (en) 1998-02-27 1999-09-02 Novo Nordisk A/S Glp-1 derivatives of glp-1 and exendin with protracted profile of action
DE69918070T2 (de) 1998-03-13 2005-08-25 Novo Nordisk A/S Stabilisierte, wässrige Glukagonlösungen, enthaltend Detergenzien
EP1119625B1 (en) 1998-10-07 2005-06-29 Medical College Of Georgia Research Institute, Inc. Glucose-dependent insulinotropic peptide for use as an osteotropic hormone
PL202367B1 (pl) 1998-12-07 2009-06-30 Sod Conseils Rech Applic Związki stanowiące analogi GLP-1, kompozycje zawierające te związki oraz zastosowanie tych związków
US20050272652A1 (en) * 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
DE60012721T4 (de) 1999-03-29 2010-09-09 Uutech Ltd., Coleraine Analoge des magensaft inhibierenden peptides und ihre verwendung für die behandlung von diabetes
GB0404124D0 (en) * 2004-02-25 2004-03-31 Univ Ulster Antagonists of GIP
ATE406384T1 (de) 2000-12-07 2008-09-15 Lilly Co Eli Glp-1 fusion proteine
US20030232761A1 (en) 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
WO2004067548A2 (en) 2003-01-31 2004-08-12 Theratechnologies Inc. Chemically modified metabolites of regulatory peptides and methods of producing and using same
BRPI0606992A2 (pt) 2005-02-11 2009-07-28 Amylin Pharmaceuticals Inc análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
TWI362392B (en) 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
JP5412273B2 (ja) 2006-03-21 2014-02-12 アミリン・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー ペプチド−ぺプチダーゼ阻害剤及びその使用
AU2007284365A1 (en) * 2006-08-17 2008-02-21 Amylin Pharmaceuticals, Inc. DPP-IV resistant GIP hybrid polypeptides with selectable properties
WO2010016936A1 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide
PL2320923T3 (pl) 2008-08-07 2015-06-30 Ipsen Pharma Sas Skrócone analogi peptydu insulinotropowego zależnego od glukozy
CA2732973A1 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Glucose-dependent insulinotropic polypeptide analogues
CN102171244B (zh) 2008-08-07 2015-05-13 益普生制药股份有限公司 糖依赖性胰岛素释放肽的类似物
US8999940B2 (en) 2008-08-07 2015-04-07 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal
US8551946B2 (en) * 2010-01-27 2013-10-08 Indiana University Research And Technology Corporation Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
US9023986B2 (en) 2010-10-25 2015-05-05 Hoffmann-La Roche Inc. Glucose-dependent insulinotropic peptide analogs
KR20140020851A (ko) * 2010-12-22 2014-02-19 마르카디아 바이오테크, 인코퍼레이트 Gip 및 glp-1 수용체-활성 글루카곤계 펩타이드를 이용한 대사장애 및 비만의 치료방법
EP2717925A1 (en) * 2011-06-10 2014-04-16 Universität Bern Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof
JP5914641B2 (ja) * 2011-06-10 2016-05-11 ベイジン・ハンミ・ファーマシューティカル・カンパニー・リミテッドBeijing Hanmi Pharmaceutical Co., Ltd. グルコース依存性インスリン分泌刺激ポリペプチドのアナログ、医薬組成物及びその使用
EP2986314A4 (en) 2013-03-15 2016-04-13 Univ Indiana Res & Tech Corp PRODRUGS WITH EXTENDED EFFECT
ES2685987T3 (es) * 2014-09-05 2018-10-15 University Of Copenhagen Análogos de péptidos gip
AU2015340586B2 (en) * 2014-10-29 2020-04-30 Zealand Pharma A/S GIP agonist compounds and methods
EP3310376A4 (en) 2015-06-17 2019-01-23 The California Institute for Biomedical Research MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
WO2018069442A1 (en) * 2016-10-12 2018-04-19 University Of Copenhagen Peptide dual agonists of gipr and glp2r
EP3560515B1 (en) 2016-12-26 2023-11-15 Kao Corporation Gip inhibitors for use in improving motor control function
EP3569248B1 (en) 2016-12-26 2023-12-06 Kao Corporation Gip inhibitors for improving cognitive function
JP7158142B2 (ja) 2016-12-26 2022-10-21 花王株式会社 低体温改善剤
BR112019025195A8 (pt) 2017-05-31 2020-07-07 Univ Copenhagen análogos do peptídeo gip de ação prolongada

Also Published As

Publication number Publication date
ES2972848T3 (es) 2024-06-17
BR112019025195A2 (pt) 2020-06-23
CN110691788B (zh) 2024-05-31
KR20200014287A (ko) 2020-02-10
KR102743887B1 (ko) 2024-12-19
BR112019025195A8 (pt) 2020-07-07
AU2018276434B2 (en) 2021-12-16
US20200087373A1 (en) 2020-03-19
CN110691788A (zh) 2020-01-14
AU2018276434A1 (en) 2020-01-02
JP2020521784A (ja) 2020-07-27
WO2018220123A1 (en) 2018-12-06
CA3064510A1 (en) 2018-12-06
EP4361173A3 (en) 2024-07-03
EP3630806B1 (en) 2024-01-10
EP4361173A2 (en) 2024-05-01
EP3630806A1 (en) 2020-04-08
US11572399B2 (en) 2023-02-07

Similar Documents

Publication Publication Date Title
SG11202105586YA (en) Modified gip peptide analogues
IL269581A (en) GIP receptor activating peptide
ZA201901253B (en) Amylin analogues
IL277483A (en) New anti-GLP-1 analogs
IL275298A (en) Mitochondria-targeted peptides
IL275129A (en) New spirobicyclic analogs
SG11201912812RA (en) Scrubber
IL253924A0 (en) Amylin analogs
ZA202000215B (en) Long-acting formulations
SG10202109234YA (en) Novel peptide
EP3645031A4 (en) PEPTIDIC ANALOGUES
PL3630806T3 (pl) Analogi peptydów gip o długotrwałym działaniu
SG11202005653RA (en) Novel peptide
PL3189072T3 (pl) Analogi peptydowe gip
GB201506316D0 (en) Novel peptide
GB201406581D0 (en) PAP Peptide analogues
IL257803B (en) Peptide analogs derived from vdac1
GB201401673D0 (en) Esculentin-2CHa peptide and analogues thereof
GB201719520D0 (en) Neuroprotectvie peptide
HK40060357A (en) Modified gip peptide analogues
GB201814440D0 (en) Peptide
GB201803074D0 (en) Peptide
GB201715378D0 (en) Peptides
GB201715379D0 (en) Peptides
GB201711620D0 (en) Peptides